Background: The most common type of arrhythmia in the USA and in European countries is atrial fibrillation (AF). The prevalence of AF is increasing worldwide with advances in technology, better prediction methods and increased awareness among healthcare professionals and patients.
| WORLDWIDE PREVALENCE OF AF BY CONTINENTS
In Europe, AF currently affects 8 million people and is expected to rise drastically, 2.3-fold by 2060. 4, 5 In the UK projections from the Clinical Practice Research Database suggest that AF will affect between 1.3 and 1.8 million people by 2060. 6 In the USA, about 3-5 million people are currently affected by AF and by 2050 this figure is expected to be greater than 8 million people. 7 In Australia, Europe and the USA, the current estimated prevalence of AF is about between 1% and 4%. 1, 4 Table 2 and Figure 2 illustrates the prevalence of AF in 9 countries, stratified by continents worldwide. Australia has the highest prevalence of AF, ie, 5.4% followed by Africa 4.6%, although the prevalence was lower (0.7%) in another African study by Shavadiva et al, 8 followed by Iceland (2.4%) and lowest in Asian countries (0.49%-1.9%).
A recent review 9 on AF epidemiology of 58 studies from 5 Asian (China, Japan, South Korea, India and Malaysia) and 8 Middle Eastern countries (Turkey, Bahrain, Qatar, Kuwait, Saudi Arabia, Oman, United
Arab Emirates and Yemen) 9 reported the annual incidence of AF to be 5.38 per 1000 person-years mainly from Chinese, Japanese and Korean studies (10 studies in total) [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] conducted from 1991 to 2012, with study populations ranging from 1485 14 to 471 446. 12 Prevalence of AF varies between hospital-based and community-based studies;
being higher in the latter (0.37%-3.56% vs 2.8%-15.8%).
9
Differences in the incidence and prevalence rates between studies is likely dependent on the time the study was conducted, the design (nationwide studies, medical insurance databases etc., retrospective, prospective, cross-sectional) and the study population (age of patients, urban compared with remote areas as their risk factors may vary, for example the prevalence of rheumatic heart disease is higher in rural populations in India) 20 which in turn effects the quality of data obtained. 
| ETHNICITY, AGE AND PREVALENCE OF AF
The prevalence of AF across different ethnic groups differs, although most of the studies investigating these differences have been conducted in the USA. For the purpose of this review, ethnicity is clas- 
AF, atrial fibrillation.
F I G U R E 1 Atrial fibrillation associated mortality stratified by sex and region (developed and developing countries) from the RE-LY AF registry which enrolled AF patients from the 164 emergency departments worldwide to evaluate the differences in the presentation and management of AF, also shows some regional variation in terms of age at AF diagnosis; patients from America and Europe countries were on average 10-12 years older than those from Africa, India and the Middle East. 
T A B L E 3 Prevalence of AF by ethnicity and race

| INCIDENCE AND PREVALENCE OF AF IN STROKE PATIENTS
AF increases the risk of stroke approximately 5 times compared with those without AF. 2 An Italian study has shown 39 the presence of AF in 24.6% of patients (mean age 78.8 ± 13.3 years) with ischaemic stroke in a population-based study, where AF is more frequent in women and patients 80 years or older. In this study, AF was an independent predictor of 30-day and 1-year mortality in Cox regression analysis. 39 Another prospective study in Germany reported an overall prevalence of AF slightly higher than the Italian study, ie, 28.6% in 692 patients with ischaemic stroke or transient ischaemic attack, with prevalence increasing with age. 40 Hanchate et al reported a similar prevalence of AF in the USA in 2013 (ie, 23% in acute ischaemic stroke patients from 8 states), 41 in 2 European studies (24.6% and 28.6%, respectively) 20, 42 and an Australian study (25%; study population 26 960). 43 However, the prevalence of AF was reportedly lower in some Asian countries, approximately 10% in China, 44 5.8%-6% in India, 45, 46 but higher in Japan (32%). 
| CONCLUSION
The prevalence of AF worldwide is increasing steadily although large variation can be seen between studies and countries. A larger proportion of ischaemic stroke patients are also found to have AF either during admission or upon investigation postdischarge that becomes a major concern as AF related to stroke has poorer outcomes and prognosis. 2, 4 This increase in the prevalence of AF may be explained by the fact that better prediction methods have been used to detect AF 1,2,49 and also greater awareness among physicians and other healthcare providers who are able to detect patients with AF during routine check-ups, flu injections and also during hospital admissions.
More epidemiological studies should perhaps be undertaken globally, especially in Asian and African countries, in urban and rural areas, so that a more accurate picture of the incidence and prevalence of AF can be captured, thereby allowing appropriate implementation of stroke prevention strategies to reduce stroke risk and burden.
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